characterized, and finally, there was a lack of confidence and training when it came to identifying patients who were at risk of diversion, misuse and overdose.
There were a few limitations to the study, including the fact that it was self-reported, and therefore susceptible to biases. Second, the response rate was low. Finally, the study was restricted to a single province in Canada (Manitoba), and therefore its results may not be indicative of a wider population’s beliefs.
Despite its limitations, the study does shed light on the fact that pharmacists, who are an integral part of the distribution of prescription drugs to patients feel ill-equipped to identify warning signs. It also provides insight into the need for more education and support for community pharmacists when it comes to preventing at-risk patients from receiving prescriptions that they may misuse.
Author: Cesar Gamboa
Cesar Gamboa is a staff reporter and editor for Addiction Now covering topics ranging from legislation to scientific studies. He was previously a general assignment reporter for the Orange County Register. SoCal raised, lover of books, and avid mountain biker (when he wants to be). He can be reached at cesarg@addictionnow.com.
